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Abstract
With over 110,000 patients waiting for organ transplantation, the current crisis in organ transplantation is based on a lack of
donors after brain-death (DBD). A very large alternative pool of donor organs that remain untapped are the donors after
cardiac death (DCD), recovered after cardiac activity has ceased and therefore sustained some ischemic injury. Machine
perfusion has been proposed as a novel modality of organ preservation and treatment to render such cadaveric organs, and
in particular livers, transplantable. Two key issues that remain unaddressed are how to assess whether a DCD liver is
damaged beyond repair, and whether machine perfusion has rendered an injured organ sufficiently viable for
transplantation. In this work, we present a metabolic analysis of the transient responses of cadaveric rat livers during
normothermic machine perfusion (NMP), and develop an index of ischemia that enables evaluation of the organ ischemic
injury level. Further, we perform a discriminant analysis to construct a classification algorithm with .0.98 specificity to
identify whether a given perfused liver is ischemic or fresh, in effect a precursor for an index of transplantability and a basis
for the use of statistical process control measures for automated feedback control of treatment of ischemic injury in DCD
livers. The analyses yield an index based on squared prediction error (SPE) as log(SPE) .1.35 indicating ischemia. The
differences between metabolic functions of fresh and ischemic livers during perfusion are outlined and the metabolites that
varied significantly for ischemic livers are identified as ornithine, arginine, albumin and tyrosine.
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Introduction
About 110,000 patients are currently on the organ transplant
waiting list in the US, with the number increasing by 5% every
year (United Network for Organ Sharing, www.unos.org, as of
July 2011). The major untapped pool of donor organs that could
be used to alleviate this crisis in organ transplantation are the
organs obtained from Donors after Cardiac Death (DCD) [1]. For
the liver, which this work focuses on, an estimated 4,000 waitlisted
patients perish every year due to a lack of transplantable organs
[2], while the estimated pool of DCD livers with ischemic time
,60 mins is on the order of 6,000 grafts per year [3].
In the absence of cardiac output, ischemic damage increases in
severity as a function of time. Beyond a certain cutoff (about
15 minutes for the heart and 30 minutes for the liver) graft
survival in the recipient falls dramatically [4]. Preclinical studies
with extracorporeal machine perfusion systems in porcine and
murine models of DCD livers [5,6,7,8,9,10,11], including from
our group [12,13,14], indicate that up to 60 minutes of warm
ischemic damage can be successfully reversed, whereas static cold
storage in preservation medium, the current clinical gold
standard, simply exacerbates the damage and recipient animals
do not survive. Research in machine perfusion systems is
subsequently a very active field in donor organ recovery and
preservation.
In humans however, cardiac death frequently occurs in
uncontrolled environments (uDCD). Without objective metrics of
ischemic duration and organ viability, uDCD organs cannot be
safely transplanted. Another benefit of machine perfusion is that
data caneasily be procured and analyzed, providingthosenecessary
metrics that describe organ status. Normothermic (37uC) Machine
Perfusion (NMP) in particular allows the organ to be metabolically
active producing measurable changes in perfusate metabolite
composition that are comparable to its in vivo counterpart.
Since hepatic metabolism is a highly integrated network which
features many metabolites that are auto- and cross-correlated in
time, univariate techniques (such as ANOVA) which ignore the
correlation structure between the metabolites and assume that
these variables are independent of each other are inadequate to
handle the problem complexity [15]. A suitable framework for
developing an index of ischemia, and more broadly quantitative
methods of organ quality control, is multivariate statistical process
monitoring (SPM) methodologies [15,16]. Multivariate SPM
techniques can look at the whole picture to identify commonalities
between different perfusions, correlations among variables as a
function of ischemia, and trends in time.
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to evaluate DCD liver injury based on the organ’s dynamic
metabolic activity during machine perfusion. To create such an
index, we first construct a multi-way principal component analysis
(MPCA) liver perfusion model that captures the correlation
structure between the metabolites during perfusion of fresh livers
that were later successfully transplanted with .1 month survival,
and defines the multivariate confidence limits for the metabolite
concentrations in the perfusion medium. Quantitative evaluation
of the process of recovery from ischemic injury by NMP is then
done on an online basis, enabling the perfusionist to apply the
necessary interventions that will optimize recovery. This is done by
projecting the metabolite concentrations for the damaged livers
onto the fresh liver MPCA model, revealing the differences in
metabolic functioning of DCD livers compared to fresh livers. We
then quantify the similarity of ischemic livers to fresh livers by
employing the Squared Prediction Error (SPE) statistic, hence
constructing an index of ischemia.
Further, we introduce an online multi-way partial least squares
discriminant analysis (MPLSDA) model to predict the end-of-
perfusion quality (i.e. ischemic or not) of a perfused liver during
perfusion. This analysis complements the ischemia index by
creating a means of classifying any given liver definitively as
ischemic or fresh, and it is proposed as the basis for a future
decision criterion of DCD liver transplantability.
Materials and Methods
Animals
Male Lewis Rats weighing 200–300 g were obtained from
Charles River Laboratories (Wilmington, MA) and maintained in
accordance with National Research Council guidelines. The
Subcommittee on Research Animal Care, Committee on
Research at the Massachusetts General Hospital, approved the
experimental protocols. All animals were allowed to acclimatize
for at least 2 days prior to any experimentation. Procured livers
were either Fresh (F; n=11) or exposed to one hour of warm
ischemia (WI; n=7) before they were placed in the perfusion
system.
Warm ischemia
Full details of the liver isolation protocol for donor livers are
explained elsewhere [14]. WI was induced by placing livers in a
temperature-controlled chamber filled with saline and maintained
at 3460.1uC for 1 hr during which time the portal vein and vena
cava were cuffed. Ex vivo ischemia ensured a constant
temperature [17] and enabled a severe model of warm ischemia
[18]. After an hour of warm ischemia, livers to be machine-
perfused were flushed with saline and then connected to the
perfusion system. Fresh livers for reperfusion were flushed through
the PV with 10 mls of saline upon clamping the vein in situ and
were then placed in a bowl of room temperature saline to be cuffed
at the PV and IVC; average warm ischemic time prior to
reperfusion was 1062 minutes.
Normothermic Liver Perfusion
The perfusion medium contained phenol red-free Williams
Medium E (WE, Sigma Chemical, St. Louis, MO). WE was
supplemented with 2 u/L insulin (28.85 units/mg Humulin, Eli
Lily, Indianapolis, IN), 100,000 u/L penicillin, 100 mg/L strep-
tomycin sulfate (Gibco, Invitrogen, Grand Island, NY), 0.292 g/L
L-glutamine (Gibco), 10 mg/L hydrocortisone (Solu-Cortef,
Pharmacia & Upjohn, Kalamazoo, MI), and 1000 u/L heparin
(APP, Schaumburg, IL). The primary circuit of the perfusion
system comprised perfusion medium (perfusate) that recirculated
by means of a peristaltic pump through a jacketed perfusion
chamber, a membrane oxygenator, a heat exchanger, and a
bubble trap. The oxygenator was gassed with a mixture of
74%N2/21%O2/5%CO2 and 100% O2 to maintain a constant
pH. Fresh rat plasma (25% v/v) and erythrocytes (18–20% v/v)
were collected earlier and added to the perfusate. The total
perfusate volume was 55 to 60 mL. Perfusate hematocrit was
sustained, nutrients were replenished, and metabolism by-products
were diluted through dialysis. A hollow fiber dialyzer with a
2200 cm
2 membrane area and a 30 kDa nominal molecular cutoff
weight (SpectrumLabs, Rancho Dominguez, CA) enabled coun-
ter-current mixing of perfusate in the primary circuit with a
reservoir of WE (dialysate) in a secondary circuit. Temperature
within the system was maintained at 37uC.
Upon completion of cuffing of fresh livers (,5 min) and after
the period of warm ischemia for WI livers, they were immersed in
perfusate in the perfusion chamber. Livers were perfused at a
constant flow rate through the portal vein while maintaining portal
pressure between 10 and 12 cmH2O. The effluent flowed freely
from the SHVC and IVC into the surrounding medium. When
the recipient hepatectomy was prepared, the liver was disconnect-
ed from the circuit, rinsed in a bowl of saline at room temperature,
and weighed again before transplantation.
Transplantation
A modification of the cuff technique designed by Kamada and
Calne [19,20,21] was implemented and is described in detail
elsewhere [14]. The anhepatic phase of the procedure was
typically 13–15 minutes and did not exceed 17 minutes. Animals
were hydrated with 8 ml/kg of warm (37uC) lactated Ringer’s
solution with 5% dextrose and 2 ml/kg of NaHCO3 7%w/v
(Abbott, North Chicago, IL) by penile vein injection.
The animals were put singly in clean cages, allowed to recover
from anesthesia under an infrared lamp for half an hour, and
subsequently returned to regular housing. During the first
12 hours post-transplantation animals were checked every 2 hours
and subsequently every 8 hours for one week, and daily
afterwards. All of the livers were successfully transplanted with
.1 month survival rate.
Metabolite Sampling
Perfusate and dialysate samples (1 mL) were collected hourly
from the liver effluent and reservoir, respectively. Perfusate
samples were first spun down at 3000 g before storing the
supernatant at 280uC. Urea was assayed by reaction with diacetyl
monoxime using a commercial assay kit (BUN, Sigma-Aldrich, St.
Louis, MO). Ketone bodies were measured enzymatically, by
following the appearance of NADH in the conversion to
acetoacetate and the disappearance of NADH in the conversion
to b-hydroxybutyrate in the presence of b-hydroxybutyrate
dehydrogenase. Eighteen of the common amino acids (except
tryptophan and cysteine) and ammonia were fluorescently labeled
using the AccQ - Tag system (Waters Co., Milford, MA),
separated by high-performance liquid chromatography (HPLC;
Model 2690, Waters Co.) and quantified by a fluorescence
detector (Model 474, Waters Co.) as previously described [22].
Lactate was measured using the enzymatic conversion to pyruvate
and hydrogen peroxide with lactate oxidase from a commercially
available kit (Trinity Biotech, Berkeley Heights, NJ). Albumin
concentration was determined by an enzyme-linked immunosor-
bent assay using a polyclonal antibody to rat albumin [23]. Note
that the dialyzer molecular cutoff weight was determined so that
albumin could not pass through, and subsequently did not appear
Metabolic Index of Ischemia of Cadaveric Livers
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quantified with an enzymatic assay kit through conversion to 6-
phospo-gluconate (Glucose assay kit, Sigma).
Statistical Preprocessing
Data consisted of 25 metabolites measured hourly for each
perfusion (Table 1). 11 Fresh livers and 7 WI livers were perfused
in total. During the initial data preprocessing obvious outliers (e.g.
negative concentrations) were eliminated and replaced by the
mean trajectory estimates [15]. The data sizes that are used for the
statistical analysis is 1162566 for fresh livers and 762566 for
damaged livers. All variables (i.e. the metabolite concentrations)
were mean-centered and unit-variance scaled for further statistical
analyses.
Multi-way Principal Component Analysis (MPCA)
While the differences in metabolic activity between fresh and
ischemic livers can be compared on a per-metabolite (i.e.
univariate) basis, since the liver is very capable of converting
these metabolites into each other such an analysis would have
problems with identifying that a large number of small differences
could also mean a significant alteration in an entire metabolic
pathway; for instance a significant alteration in urea cycle can
easily come through a combination of changes in citrulline,
ornithine, urea, and arginine concentrations in perfusion media
with individual p-values that are not significant, but the overall
fluxes over the entire pathway significantly altered; hence a
univariate analysis such as ANOVA or t-test would lead to a Type
II error, i.e. a missed alarm or false negative. Alternatively a
difference in a single metabolite could be falsely interpreted to
mean significant alteration in an entire pathway, which is a Type I
error (false alarm or false positive). In other words, evaluation of a
highly interconnected network such as the hepatic metabolism
based on a univariate analysis that does not account for the cross-
correlations between variables is expected to lead to a significant
amount of Type I and Type II errors.
Multivariate methodologies such as principal component
analysis (PCA) have been proposed for the analysis of such
datasets with many correlated variables [24,25]. PCA captures the
correlation structure between the variables and forms a model
plane with fewer dimensions which explain the largest variations in
the data, in effect distilling the many correlated variables (such as
metabolites in a pathway) into a few variables that are
uncorrelated with each other.
Briefly, PCA captures the correlation structure between the
variables in X [(I6J), j=1,…, J variables; i=1,…,I independent
samples] and forms a model plane with fewer dimensions (R
principal component (PC) directions) using only the R largest
variance directions. R is chosen such that adding additional
components to the model does not provide additional significant
information. Instead of working with highly correlated collinear
variables (X), PCA yields fewer and uncorrelated projections
(scores (T)).
X~TPTzE~^ X XzE ð1Þ
PCA is performed by singular value decomposition in the
covariance of X and the loadings P (J6R) are derived. The R
eigenvectors are the R highest variance directions. Scores, T
(I6R), are the new uncorrelated variable projections onto the
newly derived PCA plane. E is the residual matrix. Score biplots
can then be used to reveal how similar I independent samples are
to each other, reveal possible clustering among the samples and
also used in determination of outlier samples. Loading plots show
the correlation among J variables and identifies the variables that
have high influence on each model score vector t.
For Statistical Process Monitoring (SPM) of dynamic datasets,
PCA has been extended to multiway-PCA (MPCA). Multiway-
PCA is used for the analysis of three dimensional data arrays X
(I6J6K) where I independent processes are referred to as
batches (i=1,…, I). A multi-way PCA model is equivalent to an
ordinary PCA model performed on a 2D matrix constructed by
unfolding the three-way data array [15,26,27,28,29,30]. An
(I6J6K) data array can be unfolded by preserving the batch
direction I and augmenting the J variable measurements taken
at each time point k (k=1,…, K) side by side resulting in an
I6JK matrix, or by preserving the variable direction J and
augmenting the variable trajectories for different batches
resulting in a IK6J matrix (Figure 1). The former unfolding
d i r e c t i o ni st h eb e s tt ou s ei nt h eS P Mo fb a t c hp r o c e s s e ss i n c ei t
considers the batch-to-batch variations and determines the
ranges of variable trajectories during the batch. The latter
unfolding technique provides information on the extent of the
progress of a batch and can be used to determine the completion
time of a batch [31].
For the statistical modeling of fresh liver perfusions with MPCA,
an MPCA model was built using the remaining fresh liver samples
and the confidence intervals around the model plane were
determined. Later, the liver samples that were exposed to 1 hr
warm ischemia (WI) were projected onto the fresh liver model
plane, and new scores and residuals were calculated using:
^ t t~xnewP; enew~xnew{^ t tPT ð2Þ
P loadings (size (JK6R) for batch processes) are used to calculate
the new scores t (16R) using the new batch trajectory xnew
(16JK).
Squared Prediction Error (SPE). There are several
measures to quantify similarity between two batch operations
with multiple measurements at each time point, and evaluate if
they are within normal operational bounds (also termed
confidence limits). Multivariate statistics such as the Squared
Prediction Error (also called Q-statistic) are used to determine the
state of the batch progression and detect possible deviations in the
new batches (xnew,( 1 6JK)) from the reference batches
[15,26,27,28,32].
SPE, in particular, captures the large deviations from the normal
operating (NO) process that are not explained by the model and is
calculated for the new batch using the residuals enew [29],
Table 1. List of metabolites used in data analysis.
1 ACAC 10 Glutamine 19 Phenylalanine
2 Alanine 11 Glycine 20 Proline
3 Albumin 12 Histidine 21 Serine
4 Ammonia 13 Isoleucine 22 Threonine
5 Arginine 14 Lactate 23 Tyrosine
6 Asparagine 15 Leucine 24 Urea
7 Aspartate 16 Lysine 25 Valine
8 Glucose 17 Methionine
9 Glutamate 18 Ornithine
doi:10.1371/journal.pone.0028518.t001
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c~1
E2
new,c ð3Þ
SPE statistic considers the residual space and determines the
variation of a sample that is not explained by the model, hence, a
large SPE statistic indicates that the observation under consider-
ation contains a different correlation structure and is not explained
by the model. For instance, if ischemic livers contain a correlation
structure that is not captured by the fresh liver model, it will be
indicated by a large SPE value. As such, SPE effectively distills a
single quantitative variable from a large number of highly-
correlated metabolite profiles, and comparison of a perfused liver
to a set of ideal-condition livers can be accomplished simply by
comparing the SPE values to each other.
An offline analysis of the metabolite trajectories (i.e. analysis at
the end of a batch when data for all time points is ready) such as
the SPE statistic determines the events that have taken place
during the process. An online analysis (i.e. during perfusion) is
more desirable since it provides information on the events taking
place as the perfusion progresses and an estimate of the liver
viability based on the current conditions. Accordingly, online SPM
enables regulation of the process (e.g. adjusting the operational
parameters such as oxygenation, flow rate etc.) to improve the final
organ viability.
For online analysis each independent score is calculated at time
k using,
tk~xnew,jkPjk PTP
   {1
ð4Þ
where Pjk,(kJ|R) are the model loadings until time interval k.
Residuals are then calculated using enew~xnew{tkPT
k .
For such an online analysis, SPE statistic can be calculated at
each time point k (k=1 … K) for the new batch as:
SPEk~
X kJ
c~ k{1 ðÞ Jz1
e2
new,c *x2
2m2=u,a ð5Þ
x2
2m2=u,a is the critical value of the chi-squared variable with 2 m
2/
u degrees of freedom at significance level a m and u are the sample
mean (m) and variance (u) of the SPE sample at each time k [28].
Contribution plots can be used as a diagnostic tool to identify
the variables that are contributing to the deviation. The variable
contributions to SPE statistic for batch i are calculated using [33],
ContSPE i~
X K
k
X J
j
e2
jk ð6Þ
In order to quantify the total variation of each variable in the
residual space, contributions to the normalized error vector are
calculated as [34],
Normalized error Rjk~
ejk
^ s sjk
ð7Þ
where ejk is the j
th element of the residual vector enew at time k and
s ˆjk is the standard deviation of the j
th variable for the training set of
fresh livers.
Multiway Partial Least Square Discriminant Analysis
(MPLSDA). While SPEk statistic can evaluate whether a liver is
within normal operation range (i.e. how ischemic it is), for livers
that are mildly ischemic, it is possible to build on the basis of
MPCA to perform a complementary discriminant analysis to
classify a given liver either as fresh or ischemic definitively.
To be able to perform online classification of livers as ischemic
or fresh, an algorithm that can discriminate different metabolic
states from the dynamic metabolite data collected during
perfusions is required. Partial least squares or projections to latent
structures (PLS) is a regression extension of PCA and is used to
Figure 1. Unfolding of the (I6J6K) dynamic batch process data for MPCA and MPLS analyses.
doi:10.1371/journal.pone.0028518.g001
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predictor block X and response block Y. PLS gives a way of
predicting the y-values from the x-values, a generalization of
multiple regression, by correlating X to Y and finding the
orthogonal directions that maximize the correlation between X
and Y. An algorithm for Nonlinear Iterative Partial Least Squares
(NIPALS) is provided in [30].
X~TPTzE
Y~UQ
TzF ð8Þ
U~TBzH B diagonal ðÞ
Interrelation gives the predictive formulation for y.
Y~TBQ
TzF  ð9Þ
Similar to MPCA, PLS is extended to multi-way PLS (MPLS) for
batch processes. MPLS is equivalent to performing PLS where X
predictor set is the unfolded batch data and Y is a 2D matrix of
end-of-batch quality variables. The predictor set (X) consists of the
same 3-D dynamic data collected at each sampling time and
analyzed for the 25 metabolite concentrations collected, and
unfolded into a I6JK matrix as shown in Figure 1(b). For new data
coming from a new perfusion, xnew, MPLS computes the response
variables ynew using the model regression coefficients.
For prediction of the state of a liver as belonging to one of the a
priori known classes, partial least squares methodology is named
partial least squares discriminant analysis (PLSDA). PLSDA is
used to classify observations or independent experiments in the
predictor set X as belonging to one of several a-priori known
classes in Y based on their relationship. The response matrix Y
represents the class membership of each row in X by a set of
dummy variables. The dummy Y matrix consists of G columns for
G classes with 1 s and 0 s such that the g
th column is 1 and the
other columns are 0 for observations of class g (Figure 1(b)). For the
analysis of the dynamic metabolite data a multiway PLSDA
(MPLSDA) model is fit between X matrix and the dummy Y
matrix (I6G, G=2 for WI or fresh) and discriminant plane that
separates perfusions i according to their membership in a certain
class is found. When the unfolded new data xnew is projected onto
the MPLSDA model, ^ y y vector is calculated. The predicted class is
the numerical maximum of the normalized ^ y y vector.
For the analysis of fresh and ischemic livers, the (I6JK) unfolded
predictor matrix (X) consists of the metabolite trajectories for the
selected ten batches; the response matrix (Y) consists of two
columns representing the class membership of each of the ten
batches. For a fresh liver perfusion batch (class 1), the
corresponding row of Y is [1, 0], whereas, for a WI liver batch
the row is set to [0, 1].
Multi-sampling cross validation
The predictive power of MPLSDA was evaluated by case-
resampling cross validation technique [35,36]. In this approach,
the data set is sampled randomly multiple times to create training
and validation data sets. For each sampling, five samples from
fresh livers group and five samples from the WI livers are selected
randomly and the remaining samples, 5 fresh and 2 WI livers, are
used for testing the model. The maximum selection threshold for
each batch is set to 2; the maximum selection threshold is the
maximum number of times same perfusion can be used in the
same model building. The selection threshold is added to avoid the
same samples being selected most of the time.
Results
MPCA and Outlier Analysis
MPCA was used to create a model of the variability and the
correlation structure of the fresh livers metabolic function during
perfusion. The data that is used for the statistical analysis with
MPCA is 1162566 for fresh livers and 762566 for damaged
livers. Several (12 chosen out of 25) metabolite profiles during the
perfusions of fresh livers are shown in Figure 2. As it can be
observed, the mean variable trajectories change linearly with time
indicating that the system was stable during perfusion. An MPCA
model with R=3 components was built after the data is unfolded
into a (I6JK) matrix to model the batch-to-batch variation
(Figure 1(a)). First three principal components account for more
than 65% of the variability in the data.
When an MPCA model was built using all the liver samples
(n=18, 11 F and 7 WI) on a 1862566 data set, a score biplot (t1)
vs (t2) reveals the two clusters; one for fresh livers (F) and one for
WI livers (Figure 3). Formation of two different clusters is an
indication of different metabolic functioning between the two
groups. Within the groups each liver has similar metabolic
functioning, however, liver samples #7 (F) and #15 (WI) fall
away from the two clusters outside the confidence levels and
therefore were accepted as outlier samples and are not used further
in modeling.
Index of Ischemia
The MPCA model allows the calculation of SPE statistics for
each perfusion (using the residuals in Eq. 3) for fresh and WI
perfused livers. Figure 4 depicts the projection of (offline) SPE
values for all livers, along with the confidence limits for fresh livers,
demonstrating that SPE is clearly able to distinguish between fresh
and warm ischemic perfused livers.
Perhaps more interesting is the online SPEk statistics which are
calculated at each time point using Eq. 5. Figure 5 depicts the
time-evolution of the SPEk during perfusion for each liver; again
note that the SPEk statistics are online, meaning that they are
evaluated at time point k using only the data available for that liver
until that point. As shown in Figure 5, fresh livers display high
variations in SPEk values within the first 2 hours, and stabilize
afterwards. In somewhat of a contrast, the changes in SPEk for the
WI livers as a function of time are less dramatic. However,
interestingly the liver-to-liver variation between SPEk values
decreases noticeably in time for ischemic grafts (std
(SPEk)=[0.2391, 0.3951, 0.2268, 0.2484, 0.1044, 0.1463] for
t=1,…, 6 hrs respectively), and it appears that by the end of
perfusion all ischemic livers are in a very similar metabolic state
although their initial states are quite different. Still, despite this
‘‘standardization’’, the SPEk values for the WI livers always remain
outside the 99% confidence limits of fresh livers from the
beginning of the perfusion till the end, clearly demonstrating that
the perfusion-resuscitation of these organs’ metabolism does not
render them equivalent to that of fresh livers.
As Figure 5 demonstrates, the SPEk statistic quantifies and
captures the similarities and differences between ischemic and
fresh perfused livers as a group, as well as liver-to-liver variances. It
is a single number that can be calculated during perfusion from the
metabolite concentrations (see Information S1 for the full equation
used for calculations in Figure 5), and compared to existing data to
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continuous number; hence, it has the resolution and ability to
differentiate between different degrees of ischemic injury. In fact,
as displayed in Figure 5, it is capable of catching small metabolic
differences, likely small variations due to rat-to-rat differences in
metabolism, last time of eating prior to sacrifice, and small
differences in the exact ischemia duration. As such, we propose its
use as an index of ischemic injury for rat livers. Moreover, as can
be observed in Figure 5 for fresh livers, the average confidence
limits log(SPEk)i s,1.35. Accordingly, we suggest that log(SPEk)
as a heuristic limit for ischemia, with values .1.35 indicating
ischemia.
Table 2 summarizes the key metabolites that contribute to the
SPEk. Note that only the variables with higher than the 3s limits
of normal contributions are tabulated. ‘‘Normal contributions’’ are
calculated using the fresh liver perfusion profiles. Ornithine (#18),
arginine (#5), albumin (#3), and tyrosine (#23) concentrations
are significantly different between all fresh and WI livers, although
Figure 3. Score bi-plot of all liver samples measured, with 95%
and 99% confidence limits. Fresh liver sample 7 and warm ischemic
liver sample 15 fall away from the two clusters representing fresh livers
and warm ischemic livers. (1–11 fresh samples denoted by green circles,
12–18 warm ischemic samples denoted by squares).
doi:10.1371/journal.pone.0028518.g003
Figure 4. Projection of warm ischemic (WI) liver samples onto
the MPCA fresh liver model. Fresh livers are denoted by green
circles and are inside the confidence limits (blue: 95%, red: 99%),
whereas, the WI livers, denoted by squares are outside the confidence
limits.
doi:10.1371/journal.pone.0028518.g004
Figure 2. Selected metabolite concentration profiles of fresh livers during 6 hours of normothermic extracorporeal liver perfusion.
Blue solid lines show the profiles for the different perfusions of fresh livers and the black stars show the mean values.
doi:10.1371/journal.pone.0028518.g002
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glutamine and glutamate are other major contributors to the SPEk
values.
Figure 6 shows the contributions of selected metabolites to the
normalized error vector for warm ischemic livers (see Eqns 6 and
7); note that only metabolites with high contributions are shown
for clarity. Although albumin is one of the variables with large
contribution values, it is not shown in the plot for scalability.
Contributions from each perfused graft are stacked with the colors
indicating different livers. The advantage of normalized error
vector is that it can differentiate between positive and negative
variable contributions; a positive value for a particular metabolite
indicates that its concentration is higher than the fresh livers.
Overall, albumin concentrations in the WI livers are always less
than the concentrations for fresh livers. An interesting note is that
ornithine levels start negative, and switch to positive at 2 hrs and
on. Arginine concentration starts decreasing after the third hour
and drops to a minimum at time=4 hr. Tyrosine levels increase
towards the end of the perfusion.
Classification
While SPEk provides a continuous index to evaluate a given
liver, the log(SPEk).1.35 criterion suggested above is a heuristic.
The relatively wide margin of SPEk values (Figure 5) can make
classification problematic in the circumstance that a liver is equally
different from ischemic and fresh livers. Accordingly, to comple-
ment the index we built and employed an MPLS-DA model to
solve this corollary classification problem, and evaluated its
accuracy by multi-sampling cross validation.
An MPLSDA model with five fresh liver samples and five warm
ischemic liver samples using three principal components was
developed and found to explain more than 60% of the variation in
X and 99% variation in Y. The results of offline classification using
100 runs are illustrated in Figure 7. The perfusions used in the
modeling are plotted along with the projections. The perfusions
that were not used in model building (five fresh livers and two WI
livers in each run) were used to evaluate the accuracy of the model.
As it can be observed, the model correctly classifies all of the liver
samples in all 100 runs as fresh or warm ischemic (accuracy,
specificity and sensitivity=1). The test was repeated with 50 and
500 runs as well and the results did not change (results not shown).
Figure 8 shows the most important variables in determination of
class membership for each liver sample. Variable importance in
the projection (VIP) was calculated by summing the squared PLS
weights over all dimensions. The variables with VIP .1 are
effective on the response Y [16]. The most important variables
that separate WI livers from fresh livers are albumin (#3), arginine
(#5), glutamate (#9), ornithine (#18), and tyrosine (#23), similar
Figure 5. Online SPE statistic for fresh and warm ischemic
livers, denoted by green circles and black squares, respective-
ly. The solid line shows the 99% confidence limits.
doi:10.1371/journal.pone.0028518.g005
Table 2. Variable contributions to SPEk statistic.
WI Liver No. k=1 hr k=2 hr k=3 hr k=4 hr k=5 hr k=6 hr
1 Lactate Ornithine Arginine, Lactate, Ornithine Arginine, Glutamate Albumin, Ornithine Glutamate, Ornithine, Tyrosine
2 Glutamine Ornithine Arginine, Lactate Arginine, Glutamate Albumin, Ornithine Glutamate
3 Lactate Ornithine Arginine, Ornithine Arginine, Glutamate, Ornithine Albumin, Ornithine Glutamate, Ornithine, Tyrosine
4 Alanine Ornithine Arginine, Lactate, Ornithine Arginine, Glutamate Albumin, Ornithine Ornithine
5 Lactate Ornithine Tyrosine Albumin, Glutamate Albumin, Ornithine Glutamate, Tyrosine
6 Aspartate Ornithine Arginine, Ornithine Arginine Albumin, Ornithine Glutamate, Ornithine
7 Glutamine Ornithine Arginine, Ornithine Arginine, Glutamate, Ornithine Ornithine Glutamate, Tyrosine
doi:10.1371/journal.pone.0028518.t002
Figure 6. Contributions of selected metabolites to the normal-
ized error vector at each time point for WI livers. Contribution
values for each WI liver are stacked in each bar. Six figures correspond
to k=1,…,6 hr time points.
doi:10.1371/journal.pone.0028518.g006
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for MPLSDA.
With the ability of MPLSDA confirmed in offline mode, an on-
line implementation was then tested. Similar to the online ischemia
index, the basic idea is to be able to classify a perfused graft as
healthy or ischemic during perfusion so that a decision can be made
about the organ quality. Such a determination will ultimately be
necessary to identify the need for further treatments, and to build a
decision criterion for fitness of the graft for transplantation.
The prediction power of MPLS was also tested with case-
resampling cross-validation, results of classifications are given in
Table 3 for 100 resampling runs. Via online MPLS, end of
perfusion quality of a liver can be estimated hourly as the perfusion
is progressing. End-of-perfusion quality estimates for different
perfusions at each hour are shown in Figure 9. The perfusions that
are not selected via case-resampling are used for testing the MPLS
model and are shown in the figure. Fresh perfusions are denoted
by green circles, whereas, the WI liver perfusions are denoted by
black-filled squares. In order for a perfusion to be classified as a
fresh liver perfusion, the quality estimate should be greater than
0.5, else it is classified as an ischemic liver perfusion. Most of the
misclassifications occur during the first two hours and after the
third hour usually there are no misclassifications. Detailed
specificity and sensitivity values for each time point are displayed
in Table 4. As also displayed in Table 4, to ensure that the
specificity and sensitivity evaluations are not dependent on the
cross validation parameters, analysis was repeated with three
different numbers of resampling runs; indeed the variation due to
number of replicates is minimal. Moreover, specificity and
sensitivity are always above 0.98 which is excellent for online
classification. It is notable that misclassifications during online
classification are more common in the first 3 hrs, although the
difference is essentially negligible.
Figure 7. Offline classification of fresh (F) and warm ischemic
(WI) liver samples using case resampling cross-validation.
During cross-validations some of the liver samples were left out to be
used in model testing. These samples are projected onto the PLSDA
model and they are denoted as WI (squared) and F (circles). All of the
test samples for all 100 models were clustered correctly.
doi:10.1371/journal.pone.0028518.g007
Figure 8. Important variables found in MPLSDA. The most important variables that mark the differentiation of warm ischemic livers from fresh
perfused livers have VIP values greater than 1.
doi:10.1371/journal.pone.0028518.g008
Table 3. Sensitivity and specificity analyses for online quality
prediction via MPLS for 100 cross-validation runs.
WI (Actual) Fresh (Actual)
Classified as WI 599 10
Classified as Fresh 1 2990
doi:10.1371/journal.pone.0028518.t003
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In this work we introduce statistical process monitoring
methodologies for evaluation of ischemic injury of cadaveric livers
via their metabolic functions during extracorporeal perfusion. We
focused specifically on hepatic metabolism because of the large
integrated body of data with which to systemically gauge organ
functional status, compared to the more traditionally employed
singular tests of cellular injury, such as liver enzyme release (ALT
& AST) [37], oxygen uptake, [12] or ATP [38]. Our goal was to
test the hypothesis that liver metabolic performance can be
employed to evaluate the degree of ischemic injury cadaveric
organs have sustained, with the ultimate goal of developing a
metabolic feedback control scheme for optimizing organ viability
and transplantability on-line.
The multivariate analysis performed demonstrated that fresh
and ischemic rat livers display clearly distinguishable metabolic
activities. Further, it was possible to distill these differences into a
single metric, the multivariate SPEk statistic, which we; therefore
conclude that the SPEk statistic can be employed as an accurate
and continuous index of ischemic injury for perfused rat livers.
Moreover, it was demonstrated that this statistic can be computed
online during perfusion, and hence can be used in the future to
build a more sophisticated feedback-control scheme for regulation
of perfusate supplements. Based on our data, a cutoff value for
SPEk was determined to be used as a heuristic limit of ischemia.
This analysis can be further expanded to explore the correlations
between metabolic function and traditional tests of cellular injury,
and translated to human livers for a clinically applicable index of
ischemia.
We also performed a complementary discriminant analysis to
classify new livers with unknown conditions as either fresh or
ischemic. Whereas the SPEk creates a continuous index that is
ideal for utilization in on-line regulation/optimization of organ
function and viability, discriminant analysis approach enables a
final determination to be made if the organ is ready for
transplantation or not. Specificity and sensitivity of the MPLSDA
model we created were both .0.98, the accuracy of which was
tested through multi-sampling cross validation. As in the index of
ischemia/SPEk, both offline and online analysis was performed
and demonstrated to be successful in discriminating new perfusion
data. It was noted that online MPLSDA had a few misses in the
first 2 hours, and that these errors disappeared completely at
t=3 hr and on. Two possible explanations here are i) fully
sufficient data for discriminant analysis becomes available only
after three time points of evaluation, or ii) the variability among
fresh livers diminishes after the second hour when their functions
stabilize, hence allowing easier separation of fresh livers from
ischemic livers. If the latter case is valid, this might indicate that all
the perfused livers have recovered from hypoxia sufficiently to
perform measured metabolic functions, and therefore perfusion
has achieved its goal at t=3 hrs and further perfusion is not
necessary. In fact, the ability to identify when the liver is ready for
transplantation would be very valuable for clinical utility of
perfusion systems as such a measure is currently not available.
However, it is important to note though that while the models
proposed and developed in this work can identify the degree of
ischemia, they cannot be used for evaluation of transplantability
since all the livers perfused were successfully transplanted.
However, this model can be the basis for determining transplant-
ability if data from extended ischemic organs where recipients fail
is included in the data. Testing by further transplantation at
shorter perfusion durations is necessary for development of such
an index.
The multivariate SPEk statistic identified arginine, ornithine,
albumin, tyrosine, lactate, glutamate, with the addition on
acetoacetate in the MPLSDA model, as key metabolites that
distinguished fresh from ischemic livers. The majority of these
metabolites are directly associated with ischemia-induced pathway
alterations. Arginine, for instance, is a precursor to both the
vasodilator nitric oxide (NO) and ornithine. The balance between
arginases (producing ornithine) and nitric oxide synthases
(producing NO and citrulline) are dramatically altered during
hypoxia [39,40,41]. This may account for the significantly higher
rate of arginine depletion observed in WI livers compared to Fresh
livers (Figure 6), with a concomitant increase in ornithine
production (Figure 6). Tyrosine, normally catalyzed in the liver
to acetoacetate and fumarate, acts a precursor to nitrotyrosine, a
derivative of altered NO metabolism, the increased presence of
which may be associated with suboptimal levels of arginine [42].
Further investigations to elucidate the role of arginine in hepatic
microvasculature preservation, and verification of the dominant
by-products of tyrosine metabolism during perfusion of Fresh and
WI livers, will enable optimal priming of the perfusate to minimize
reperfusion injury. Albumin is a negative acute phase protein such
that its production decreases when hepatocytes are stressed.
Interestingly, a known trigger that reduces albumin synthesis is
Figure 9. Online classification for fresh and warm ischemic
metabolite profiles using case resampling cross validation.
Fresh liver samples and warm ischemic livers are represented by circles
(.0.5) and squares (,0.5), respectively. Results shown for 50 runs with
10 random livers selected equally from fresh and WI samples.
doi:10.1371/journal.pone.0028518.g009
Table 4. Sensitivity and specificity analyses for online quality
prediction using MPLS for 50, 100 and 1000 runs.
Criterion k=1 hr k=2 hr k=3 hr k=4 hr k=5 hr k=6 hr
S e n s i t i v i t y ( 5 0 r u n s ) 110 . 9 8 0 111
Specificity (50 runs) 0.988 0.984 0.992 1 1 1
S e n s i t i v i t y ( 1 0 0 r u n s ) 110 . 9 9 0 111
Specificity (100 runs) 0.986 0.9940 1 1 1 1
Sensitivity (1000 runs) 0.995 1 0.997 1 0.999 1
Specificity (1000 runs) 0.984 0.990 0.997 1 1 1
doi:10.1371/journal.pone.0028518.t004
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expenditure during hypoxia [43]; the effects may last for several
hours [44]. From our findings, albumin synthesis in WI livers
remained flat for the duration of perfusion, while Fresh livers
began to recover by t=2 hours. Lactate is a by-product of
anaerobic metabolism; while cells will secrete lactate into a
perfusate devoid of any lactate [45], lactate production exceeding
this rate by WI livers in the first hour of perfusion suggests a
response to their inadequate oxygen supply (Figure 6). Glutamate
production as a marker of amino acid transamination increases
throughout perfusion of Fresh livers, but is constant in WI livers.
This would be consistent with the overall reduction in protein
synthesis by WI livers, requiring less amino acid degradation, or an
upregulation of the urea cycle by these livers, driven by their
increased arginine consumption.
The analyses performed in this work all confirm that a
metabolic index of ischemic injury is a feasible idea for evaluation
of perfused ischemic livers, and such a measure would be of
significant use in utilization of DCD livers for transplantation.
Similar data for human livers is not available; however, in
principle, the proposed methodology can similarly be applied to
human livers in a clinical setting. This study demonstrates the
power of SPM methodologies in achieving this goal; however,
further work is needed to reach an index of transplantability. The
data gathered here can also be used for more sophisticated
metabolic analyses which reveal more details of the cellular
function [46,47,48].
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